Appointment booking for Dr. Mohammed Khalid, MD is currently not available.Dr. Mohammed Khalid, MD has not yet fully activated their profile on DiabetesIQ.
Dr. Mohammed Khalid, MD (he/him) is a Nephrologist in Waldorf, MD with over 18 years of experience. What is your opinion of Dr. Mohammed Khalid, MD? Rate this provider below so other people can make informed decision.
Gender
Male
Experience
Over 18 Years of Experience
Languages Spoken
English
Accepted Insurances
Medicare
Payments Received
Many providers receive payments from medical companies such as pharmaceutical companies and medical device companies. These payments can range from small amounts for meals to large consulting fees. We provide this information in order to make healthcare system more transparent. Between 2014 and 2020 Dr. Mohammed Khalid, MD has received over $776 which includes payments from the following companies:
$201.62 from Amniox Medical
$86.50 from Amgen Inc.
$69.99 from GlaxoSmithKline, LLC.
$64.33 from Keryx Biopharmaceuticals, Inc.
$50.86 from Questcor Pharmaceuticals
$50.45 from AstraZeneca Pharmaceuticals LP
$31.29 from Smith & Nephew, Inc.
$30.65 from Allergan Inc.
$29.51 from OPKO Pharmaceuticals, LLC
$25.40 from Takeda Pharmaceuticals America, Inc.
$23.13 from sanofi-aventis U.S. LLC
$22.48 from Relypsa, Inc.
$14.81 from Horizon Pharma plc
$14.68 from Novartis Pharmaceuticals Corporation
$13.22 from Genentech USA, Inc.
$12.41 from EPI Health, LLC
$11.98 from Otsuka America Pharmaceutical, Inc.
$11.58 from Mallinckrodt LLC
$11.52 from Merck Sharp & Dohme Corporation
Payments received by Dr. Mohammed Khalid, MD were from the following categories:
Do you have any questions about your diabetes condition or general questions about diabetes? You can now post those questions in DiabetesIQ Forum and have our diabetes experts answer your questions for FREE! Yes, there is absolutely no catch! - Registration only takes a few seconds and it's FREE. No credit card needed. You can ask any number of diabetes questions, all for FREE! Register today and join the conversation!